Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
16.98
-0.08 (-0.47%)
Apr 8, 2026, 3:03 PM EDT - Market open
Erasca Market Cap
Erasca has a market cap or net worth of $5.28 billion as of April 8, 2026. Its market cap has increased by 1,117.68% in one year.
Market Cap
5.28B
Enterprise Value
5.00B
1-Year Change
1,117.68%
Ranking
Category
Stock Price
$16.98
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $5.28B, an increase of 183.99%. That is a compound annual growth rate of 24.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 5.30B | 402.39% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Terns Pharmaceuticals | 6.08B |
| Rhythm Pharmaceuticals | 5.89B |
| Scholar Rock Holding | 5.75B |
| CG Oncology | 5.70B |
| Mirum Pharmaceuticals | 5.68B |
| Cogent Biosciences | 5.67B |
| PTC Therapeutics | 5.61B |
| Caris Life Sciences | 5.45B |